My work is a 
story of molecules.

Small-scale analysis, large-scale impact.

Galyna | Supervising Senior Scientist

I lead a group of scientists who are part of the Downstream Process Development (DSP) team. The DSP team represents the first and main link between the customer and our Biologics API business, which is part of Pharma Services at Thermo Fisher Scientific. My team and I work on the process to manufacture drugs used to treat illnesses like gastric, pancreatic, breast and ovarian cancers as well as diseases like rheumatoid arthritis and lupus.

We focus on two types of programs. The first entails manufacturing drugs and therapies using the molecules provided by a customer. Molecules are the basis of every treatment. Before any of the manufacturing happens, our team has to ensure the process to create the treatment is perfect. We test the processes on a small scale before approving the molecule for manufacturing. This is the best way to confirm that the molecule will be safe to be manufactured on a large scale for clinical trials and commercialization.

The second program that we work on is the full development of a treatment. In this instance, a customer asks us to identify the right molecule to be used in treatment and then follow the same development processes in the first program.

The team strives to stay at the forefront of the industry by utilizing the newest technologies, leading developments, implementing pilot programs and participating in studies in an effort to launch new products. Our end goal is to supply quality products in a timely manner to the patients in need.

We contribute to Thermo Fisher’s Mission—to enable our customers to make the world healthier, cleaner and safer — by developing drugs used to treat extremely serious, and sometimes fatal, diseases. Knowing that my hard work and dedication results in saving or improving someone’s life and health by helping to treat rare diseases and cancer is extremely rewarding for me.